Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Rational drug design of antiviral compounds using a novel in silico approach combining quantum chemistry and bioinformatics

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: TOKIWA, Hiroaki (Rikkyo Universiry, Department of Chemistry, Tokyo, Japan)
  • Co-author(s): Naoya Matsuo: Department of Chemistry, Rikkyo Universiry, Tokyo, Japan
    Yurina Miyashita: Department of Chemistry, Rikkyo Universiry, Tokyo, Japan
    Shogo Nakano: Department of Food Sciences, University of Shizuoka, Shizuoka, Japan
    Shohei Ito: Department of Food Sciences, University of Shizuoka, Shizuoka, Japan
    Mark von Itzstein: Institute for Glycomics, Griffith Unviersity, Gold Coast, Australia
    Hiroaki Tokiwa: Department of Chemistry, Rikkyo Universiry, Tokyo, Japan
  • Abstract:

    Backgrounds

    Human parainfluenza viruses (hPIVs), type 1 – 4, are serious human pathogenic ones that cause upper and lower respiratory tract diseases in infants and young children, and also impact the elderly and immunocompromised patients. Neither effective clinical vaccines nor antiviral drugs are developed to treat the parainfluenza virus..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses